Frederick Baehner
Frederick Baehner
Verified email at - Homepage
Cited by
Cited by
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, FL Baehner, ...
New England Journal of Medicine 351 (27), 2817-2826, 2004
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
RM Neve, K Chin, J Fridlyand, J Yeh, FL Baehner, T Fevr, L Clark, ...
Cancer cell 10 (6), 515-527, 2006
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor–positive breast cancer
S Paik, G Tang, S Shak, C Kim, J Baker, W Kim, M Cronin, FL Baehner, ...
Journal of clinical oncology 24 (23), 3726-3734, 2006
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ...
Annals of oncology 26 (2), 259-271, 2015
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a …
KS Albain, WE Barlow, S Shak, GN Hortobagyi, RB Livingston, IT Yeh, ...
The lancet oncology 11 (1), 55-65, 2010
Breast cancer prognostic classification in the molecular era: the role of histological grade
EA Rakha, JS Reis-Filho, F Baehner, DJ Dabbs, T Decker, V Eusebi, ...
Breast cancer research 12 (4), 1-12, 2010
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
S Badve, DJ Dabbs, SJ Schnitt, FL Baehner, T Decker, V Eusebi, SB Fox, ...
Modern pathology 24 (2), 157-167, 2011
Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with …
M Dowsett, J Cuzick, C Wale, J Forbes, EA Mallon, J Salter, E Quinn, ...
J Clin Oncol 28 (11), 1829-1834, 2010
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling
EA Klein, MR Cooperberg, C Magi-Galluzzi, JP Simko, SM Falzarano, ...
European urology 66 (3), 550-560, 2014
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade
B Weigelt, FL Baehner, JS Reis‐Filho
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2010
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast
LJ Solin, R Gray, FL Baehner, SM Butler, LL Hughes, C Yoshizawa, ...
Journal of the National Cancer Institute 105 (10), 701-710, 2013
β1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and …
CC Park, H Zhang, M Pallavicini, JW Gray, F Baehner, CJ Park, MJ Bissell
Cancer research 66 (3), 1526-1535, 2006
Validation study of a quantitative multigene reverse transcriptase–polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer
RG Gray, P Quirke, K Handley, M Lopatin, L Magill, FL Baehner, ...
Journal of clinical oncology 29 (35), 4611-4619, 2011
Breast cancer growth prevention by statins
MJ Campbell, LJ Esserman, Y Zhou, M Shoemaker, M Lobo, E Borman, ...
Cancer research 66 (17), 8707-8714, 2006
Prognostic utility of the 21-gene assay in hormone receptor–positive operable breast cancer compared with classical clinicopathologic features
LJ Goldstein, R Gray, S Badve, BH Childs, C Yoshizawa, S Rowley, ...
Journal of Clinical Oncology 26 (25), 4063, 2008
Bladder cancer outcome and subtype classification by gene expression
E Blaveri, JP Simko, JE Korkola, JL Brewer, F Baehner, K Mehta, ...
Clinical Cancer Research 11 (11), 4044-4055, 2005
Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus …
MJ O'Connell, I Lavery, G Yothers, S Paik, KM Clark-Langone, M Lopatin, ...
Journal of clinical oncology 28 (25), 3937, 2010
Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome
MJ Campbell, NY Tonlaar, ER Garwood, D Huo, DH Moore, AI Khramtsov, ...
Breast cancer research and treatment 128, 703-711, 2011
Comparison of the performance of 6 prognostic signatures for estrogen receptor–positive breast cancer: a secondary analysis of a randomized clinical trial
I Sestak, R Buus, J Cuzick, P Dubsky, R Kronenwett, C Denkert, S Ferree, ...
JAMA oncology 4 (4), 545-553, 2018
Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study
LJ Solin, R Gray, LL Hughes, WC Wood, MA Lowen, SS Badve, ...
Journal of Clinical Oncology 33 (33), 3938, 2015
The system can't perform the operation now. Try again later.
Articles 1–20